EXTENDICARE INC (EXE.CA) Stock Fundamental Analysis
TSX:EXE - Toronto Stock Exchange - CA30224T8639 - Common Stock - Currency: CAD
Overall EXE gets a fundamental rating of 6 out of 10. We evaluated EXE against 14 industry peers in the Health Care Providers & Services industry. While EXE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. EXE has a decent growth rate and is not valued too expensively. Finally EXE also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year EXE was profitable.
EXE had a positive operating cash flow in the past year.
Each year in the past 5 years EXE has been profitable.
Each year in the past 5 years EXE had a positive operating cash flow.
1.2 Ratios
The Return On Assets of EXE (10.81%) is better than 85.71% of its industry peers.
EXE's Return On Equity of 61.61% is amongst the best of the industry. EXE outperforms 92.86% of its industry peers.
EXE has a better Return On Invested Capital (20.15%) than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EXE is above the industry average of 8.13%.
The 3 year average ROIC (11.40%) for EXE is below the current ROIC(20.15%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.81% | ||
| ROE | 61.61% | ||
| ROIC | 20.15% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
1.3 Margins
With a decent Profit Margin value of 5.23%, EXE is doing good in the industry, outperforming 71.43% of the companies in the same industry.
EXE's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 7.91%, EXE is doing good in the industry, outperforming 71.43% of the companies in the same industry.
EXE's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 14.04%, EXE is doing worse than 85.71% of the companies in the same industry.
EXE's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.91% | ||
| PM (TTM) | 5.23% | ||
| GM | 14.04% |
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
2. Health
2.1 Basic Checks
EXE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
EXE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for EXE has been reduced compared to 5 years ago.
EXE has a better debt/assets ratio than last year.
2.2 Solvency
EXE has an Altman-Z score of 3.02. This indicates that EXE is financially healthy and has little risk of bankruptcy at the moment.
EXE has a Altman-Z score of 3.02. This is in the better half of the industry: EXE outperforms 78.57% of its industry peers.
The Debt to FCF ratio of EXE is 128.12, which is on the high side as it means it would take EXE, 128.12 years of fcf income to pay off all of its debts.
EXE has a Debt to FCF ratio of 128.12. This is comparable to the rest of the industry: EXE outperforms 50.00% of its industry peers.
EXE has a Debt/Equity ratio of 2.16. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.16, EXE is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.16 | ||
| Debt/FCF | 128.12 | ||
| Altman-Z | 3.02 |
ROIC/WACC2.88
WACC6.99%
2.3 Liquidity
A Current Ratio of 0.84 indicates that EXE may have some problems paying its short term obligations.
EXE has a Current ratio (0.84) which is in line with its industry peers.
EXE has a Quick Ratio of 0.84. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
EXE has a Quick ratio (0.84) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
EXE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 115.90%, which is quite impressive.
EXE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.74% yearly.
Looking at the last year, EXE shows a quite strong growth in Revenue. The Revenue has grown by 9.38% in the last year.
The Revenue has been growing slightly by 5.31% on average over the past years.
EPS 1Y (TTM)115.9%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%27.83%
Revenue 1Y (TTM)9.38%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%2.06%
3.2 Future
The Earnings Per Share is expected to grow by 8.74% on average over the next years. This is quite good.
EXE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.74% yearly.
EPS Next Y-4.22%
EPS Next 2Y4.74%
EPS Next 3Y7.81%
EPS Next 5Y8.74%
Revenue Next Year8.95%
Revenue Next 2Y6.76%
Revenue Next 3Y5.17%
Revenue Next 5Y4.74%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 16.51, the valuation of EXE can be described as correct.
Based on the Price/Earnings ratio, EXE is valued cheaper than 85.71% of the companies in the same industry.
When comparing the Price/Earnings ratio of EXE to the average of the S&P500 Index (27.45), we can say EXE is valued slightly cheaper.
With a Price/Forward Earnings ratio of 15.65, EXE is valued correctly.
Based on the Price/Forward Earnings ratio, EXE is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
EXE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.51 | ||
| Fwd PE | 15.65 |
4.2 Price Multiples
85.71% of the companies in the same industry are more expensive than EXE, based on the Enterprise Value to EBITDA ratio.
EXE's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 512.88 | ||
| EV/EBITDA | 8.88 |
4.3 Compensation for Growth
EXE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.73
EPS Next 2Y4.74%
EPS Next 3Y7.81%
5. Dividend
5.1 Amount
EXE has a Yearly Dividend Yield of 3.65%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.25, EXE pays a better dividend. On top of this EXE pays more dividend than 85.71% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, EXE pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.65% |
5.2 History
The dividend of EXE has a limited annual growth rate of 2.79%.
EXE has been paying a dividend for at least 10 years, so it has a reliable track record.
EXE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.79%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
51.91% of the earnings are spent on dividend by EXE. This is a bit on the high side, but may be sustainable.
EXE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP51.91%
EPS Next 2Y4.74%
EPS Next 3Y7.81%
TSX:EXE (7/4/2025, 7:00:00 PM)
13.7
-0.07 (-0.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners24.58%
Inst Owner ChangeN/A
Ins Owners13.13%
Ins Owner ChangeN/A
Market Cap1.15B
Analysts74
Price Target16.41 (19.78%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.65% |
Yearly Dividend0.48
Dividend Growth(5Y)2.79%
DP51.91%
Div Incr Years1
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.88%
PT rev (3m)22.54%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)5.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.51 | ||
| Fwd PE | 15.65 | ||
| P/S | 0.78 | ||
| P/FCF | 512.88 | ||
| P/OCF | 22.84 | ||
| P/B | 9.17 | ||
| P/tB | 191.33 | ||
| EV/EBITDA | 8.88 |
EPS(TTM)0.83
EY6.06%
EPS(NY)0.88
Fwd EY6.39%
FCF(TTM)0.03
FCFY0.19%
OCF(TTM)0.6
OCFY4.38%
SpS17.58
BVpS1.49
TBVpS0.07
PEG (NY)N/A
PEG (5Y)0.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.81% | ||
| ROE | 61.61% | ||
| ROCE | 26.66% | ||
| ROIC | 20.15% | ||
| ROICexc | 26.88% | ||
| ROICexgc | 42.25% | ||
| OM | 7.91% | ||
| PM (TTM) | 5.23% | ||
| GM | 14.04% | ||
| FCFM | 0.15% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
ROICexc(3y)15.38%
ROICexc(5y)13.52%
ROICexgc(3y)24.33%
ROICexgc(5y)19.82%
ROCE(3y)15.09%
ROCE(5y)13.42%
ROICexcg growth 3Y72.34%
ROICexcg growth 5Y37.48%
ROICexc growth 3Y55.61%
ROICexc growth 5Y29.1%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
F-Score7
Asset Turnover2.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.16 | ||
| Debt/FCF | 128.12 | ||
| Debt/EBITDA | 1.8 | ||
| Cap/Depr | 143.57% | ||
| Cap/Sales | 3.26% | ||
| Interest Coverage | 9.47 | ||
| Cash Conversion | 33.51% | ||
| Profit Quality | 2.9% | ||
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 3.02 |
F-Score7
WACC6.99%
ROIC/WACC2.88
Cap/Depr(3y)281.27%
Cap/Depr(5y)221.87%
Cap/Sales(3y)7.03%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)115.9%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%27.83%
EPS Next Y-4.22%
EPS Next 2Y4.74%
EPS Next 3Y7.81%
EPS Next 5Y8.74%
Revenue 1Y (TTM)9.38%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%2.06%
Revenue Next Year8.95%
Revenue Next 2Y6.76%
Revenue Next 3Y5.17%
Revenue Next 5Y4.74%
EBIT growth 1Y90.12%
EBIT growth 3Y30.79%
EBIT growth 5Y16.11%
EBIT Next Year-5.03%
EBIT Next 3Y4.16%
EBIT Next 5Y2.88%
FCF growth 1Y102.3%
FCF growth 3YN/A
FCF growth 5Y53.33%
OCF growth 1Y173.94%
OCF growth 3Y31.32%
OCF growth 5Y26.02%